Open programs1
The LAM Foundation 2026 Grant Program — Pilot-Feasibility, Clinical Research, and Patient Quality of Life Awards
The LAM Foundation’s 2026 grant program funds innovative scientific and clinical research on lymphangioleiomyomatosis (LAM), with priority areas including discovery or repurposing of therapies (including combinations with mTOR inhibitors), new therapeutic targets, sex as a biological variable, and projects that improve patient quality of life.
- Deadline
- Not listed
- Amount
- $50,000
Program details are the catalog's own fields as FundFit holds them: title, category, deadline, and amount. For the full listing and eligibility, follow the funder's site.